Gemechu Jifare, Gebremichael Bereket, Tesfaye Tewodros, Seyum Alula, Erkalo Desta
College of Medicine and Health Sciences, Wachemo University, Hosanna, Ethiopia.
College Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Arch Public Health. 2022 Jan 4;80(1):11. doi: 10.1186/s13690-021-00713-1.
Co-infection of tuberculosis and HIV has a significant impact on public health. TB is the most common opportunistic infection and the leading cause of death in HIV-positive children worldwide. But there is paucity of studies concerning the predictors of mortality among TB-HIV co-infected children. This study aimed to determine the predictors of mortality among TB-HIV co-infected children attending ART clinics of public hospitals in Southern Nation, Nationalities and Peoples Region (SNNPR), Ethiopia.
A hospital-based retrospective cohort study design was used among 284 TB-HIV co-infected children attending ART clinics at selected public hospitals in SNNPR, Ethiopia, from January 2009 to December 2019. Then, medical records of children who were TB/HIV co-infected and on ART were reviewed using a structured data extraction tool. Data were entered using Epidata 4.6 and analyzed using SPSS version 23. The Kaplan Meier survival curve along with log rank tests was used to estimate and compare survival time. Bivariable and multivariable analyses were conducted to identify predictors of mortality among TB/HIV co-infected children. Adjusted Hazard Ratio with p value < 0.05 and 95% confidence interval was considered statistically significant.
A total of 284 TB/HIV co-infected children were included in the study. Among these, 35 (12.3%) of them died during the study period. The overall mortality rate was 2.78 (95%CI = 1.98-3.99) per 100 child years of observation. The predictors of mortality were anemia (AHR = 3.6; 95%CI: 1.39-9.31), fair or poor ART drug adherence (AHR = 2.9; 95%CI = 1.15-7.43), extrapulmonary TB (AHR = 3.9; 95%CI: 1.34-11.45) and TB drug resistance (AHR = 5.7; 95%CI: 2.07-15.96).
Mortality rate of TB/HIV co-infected children in selected public hospitals in SNNPR, Ethiopia was documented as 2.78 per child years of observation as a result of this study. Moreover, Anemia, drug resistant tuberculosis, extrapulmonary TB and poor adherence to ART drugs were identified as the predictors of mortality among these children.
结核病与艾滋病病毒合并感染对公共卫生有重大影响。结核病是最常见的机会性感染,也是全球艾滋病毒阳性儿童的主要死因。但关于结核病与艾滋病毒合并感染儿童死亡率预测因素的研究较少。本研究旨在确定埃塞俄比亚南方民族与人民地区(SNNPR)公立医院抗逆转录病毒治疗(ART)门诊中结核病与艾滋病毒合并感染儿童的死亡率预测因素。
采用基于医院的回顾性队列研究设计,对2009年1月至2019年12月期间在埃塞俄比亚SNNPR选定公立医院的抗逆转录病毒治疗门诊就诊的284例结核病与艾滋病毒合并感染儿童进行研究。然后,使用结构化数据提取工具回顾结核病/艾滋病毒合并感染且正在接受抗逆转录病毒治疗儿童的病历。数据使用Epidata 4.6录入,并使用SPSS 23版进行分析。采用Kaplan-Meier生存曲线和对数秩检验来估计和比较生存时间。进行双变量和多变量分析以确定结核病/艾滋病毒合并感染儿童死亡率的预测因素。调整后的风险比p值<0.05且95%置信区间被认为具有统计学意义。
本研究共纳入284例结核病/艾滋病毒合并感染儿童。其中,35例(12.3%)在研究期间死亡。每100儿童年观察期的总死亡率为2.78(95%CI = 1.98 - 3.99)。死亡率的预测因素为贫血(调整后风险比[AHR]=3.6;95%CI:1.39 - 9.31)、抗逆转录病毒药物依从性一般或较差(AHR = 2.9;95%CI = 1.15 - 7.43)、肺外结核(AHR = 3.9;95%CI:1.34 - 11.45)和结核耐药(AHR = 5.7;95%CI:2.07 - 15.96)。
本研究记录了埃塞俄比亚SNNPR选定公立医院中结核病/艾滋病毒合并感染儿童每儿童年观察期的死亡率为2.78。此外,贫血、耐药结核病、肺外结核和抗逆转录病毒药物依从性差被确定为这些儿童死亡率的预测因素。